EUVIMEDEUVIMED entdecken
Crossref

Insights into nanostructured lipid carriers of etoricoxib for mitigating radiation‐induced lung inflammation and exploring anti‐inflammatory mechanisms in rats

Sahar Khateeb iD, Amal I Hassan iD

Fundamental & Clinical Pharmacology · 2025

DOI: 10.1111/fcp.70014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, 2025. Verfasst von Sahar Khateeb und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Science, University of Tabuk, Tabuk, 71491, Saudi Arabia. Hauptthemen laut MEDLINE: Etoricoxib, Nanostructures, Anti-Inflammatory Agents, Radiation Injuries, Experimental. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Radiation exposure can cause inflammation, which etoricoxib (ET), an anti‐inflammatory drug, could potentially mitigate.

Objective

This study aimed to evaluate the potential effectiveness of etoricoxib‐loaded nanostructured lipid carriers (ET‐NLCs) in mitigating radiation‐induced acute lung inflammation in rats.

Methods

Thirty‐six rats were divided into six groups. Group 1 (C): control; group 2 (ET): normal rats given ET (10 mg/kg) orally for 14 days; group 3 (ET‐NLC): normal rats administered ET‐NLCs orally (10 mg/kg) for 14 days. Group 4 (R): rats exposed to 6 Gy whole‐body gamma radiation, untreated thereafter to induce lung inflammation and injury. Group 5 (ET‐R), irradiated rats, were administered ET (10 mg/kg) orally daily for 14 days. Group 6 (ET‐NLC‐R), irradiated rats, were administered ET‐NLCs (10 mg/kg) orally daily for 14 days. Molecular, biochemical, and histopathological analyses were performed to assess inflammation, apoptosis, oxidative stress, and lung tissue architecture.

Results

Radiation exposure led to a 1053% increase in Bax expression and an 81.5% decrease in Bcl‐2, indicating heightened apoptosis. ET‐NLCs treatment reversed these effects, reducing Bax by 59.9% and increasing Bcl‐2 by 337.4%. Additionally, ET‐NLCs reduced caspase‐3 and caspase‐8 activation by 54.5% and 62.9%, respectively, compared to radiation exposure alone. Furthermore, ET‐NLCs demonstrated potent anti‐inflammatory effects by reducing interleukin‐6 (IL‐6) and tumor necrosis factor‐alpha (TNF‐α) levels by 49% and 39%, respectively, compared to the irradiated group. Radiation increased malondialdehyde (MDA) levels by 388%, indicating oxidative damage, and suppressed antioxidant enzymes such as catalase (CAT), glutathione peroxidase (GPX), and superoxide dismutase (SOD). ET‐NLC treatment decreased MDA levels and increased CAT, GPX, and SOD by 35.7%, 4766.7%, and 765.9%, respectively, restoring antioxidant balance. Radiation reduced surfactant protein (SP‐D) levels to 4.9% of control values, but ET‐NLCs treatment restored them to 14%. Histopathological analysis revealed that radiation‐exposed lungs showed thickened inter‐alveolar septa, emphysematous areas, and inflammatory infiltration. ET‐NLCs treatment exhibited only mild thickening and limited inflammatory cell infiltration, suggesting significant improvement in lung architecture.

Conclusions

Based on these results, NLCs are one of the most promising ways to deliver anti‐inflammatory drugs for treating lung damage caused by radiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EtoricoxibNanostructuresAnti-Inflammatory AgentsRadiation Injuries, ExperimentalRadiation PneumonitisAnimalsRatsMaleLipidsOxidative StressDrug CarriersLungApoptosisRats, Wistar

Stichwörter der Autor:innen

antioxidantsapoptosisgamma irradiationlung toxicitynanostructured lipid carrierstargeted drug delivery

Substanzen

EtoricoxibAnti-Inflammatory AgentsLipidsDrug Carriers

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Science, University of Tabuk, Tabuk, 71491, Saudi Arabia.
  • Biochemistry Division, Department of Chemistry, Faculty of Science, Fayoum University, Fayoum, Egypt.
  • Radioisotopes Department, Nuclear Research Centre, Egyptian Atomic Energy Authority, Giza, Egypt.

ORCID-Profile: Sahar Khateeb, Amal I Hassan

Zitieren

APA

Khateeb, S., & Hassan, A. I. (2025). Insights into nanostructured lipid carriers of etoricoxib for mitigating radiation‐induced lung inflammation and exploring anti‐inflammatory mechanisms in rats. Fundamental & Clinical Pharmacology. https://doi.org/10.1111/fcp.70014

Vancouver

Khateeb S, Hassan AI. Insights into nanostructured lipid carriers of etoricoxib for mitigating radiation‐induced lung inflammation and exploring anti‐inflammatory mechanisms in rats. Fundamental & Clinical Pharmacology. 2025. doi:10.1111/fcp.70014

BibTeX
@article{Khateeb2025,
  author = {Khateeb, Sahar and Hassan, Amal I},
  title = {Insights into nanostructured lipid carriers of etoricoxib for mitigating radiation‐induced lung inflammation and exploring anti‐inflammatory mechanisms in rats},
  journal = {Fundamental & Clinical Pharmacology},
  year = {2025},
  doi = {10.1111/fcp.70014}
}
Kostenlos starten →